Cargando…

Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation

BACKGROUND: Progestin-primed ovarian stimulation (PPOS) has been used in infertility cases in recent years, and several reports have stated that it has oocyte collection results similar to those of gonadotropin-releasing hormone antagonist (GnRH-ant) protocol. For emergency fertility preservation, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Haipeng, Itaya, Yukiko, Samejima, Kouki, Ichinose, Shunichiro, Narita, Tatsuya, Matsunaga, Shigetaka, Saitoh, Masahiro, Takai, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725433/
https://www.ncbi.nlm.nih.gov/pubmed/34983605
http://dx.doi.org/10.1186/s13048-021-00935-5
_version_ 1784626115912925184
author Huang, Haipeng
Itaya, Yukiko
Samejima, Kouki
Ichinose, Shunichiro
Narita, Tatsuya
Matsunaga, Shigetaka
Saitoh, Masahiro
Takai, Yasushi
author_facet Huang, Haipeng
Itaya, Yukiko
Samejima, Kouki
Ichinose, Shunichiro
Narita, Tatsuya
Matsunaga, Shigetaka
Saitoh, Masahiro
Takai, Yasushi
author_sort Huang, Haipeng
collection PubMed
description BACKGROUND: Progestin-primed ovarian stimulation (PPOS) has been used in infertility cases in recent years, and several reports have stated that it has oocyte collection results similar to those of gonadotropin-releasing hormone antagonist (GnRH-ant) protocol. For emergency fertility preservation, random-start ovarian stimulation is usually recommended. Therefore we compared the clinical outcomes of random-start PPOS with those of conventional random-start GnRH-ant protocols in fertility-preserving cases. METHODS: We retrospectively examined 86 cycles of oocyte collection, of which 56 were random-start GnRH-ant and 30 were random-start PPOS for fertility preservation at our hospital between January 2016 and April 2021. The primary outcome was the number of mature oocytes per cycle. The secondary outcome was the number of vitrified blastocysts per cycle for embryo freezing cases. RESULTS: No significant differences were noted in the number of days of stimulation, total dose of gonadotropin preparation, and the number of mature oocytes and vitrified blastocysts. The number of hospital visits for monitoring was significantly lower in the PPOS group. The start of menstruation before oocyte collection was significantly less in the PPOS group. CONCLUSIONS: Random-start PPOS and GnRH-ant were similar in oocyte collection results. PPOS can reduce the number of hospital visits, thus reducing patient stress. PPOS at the start of the luteal phase can prevent the start of menstruation during ovarian stimulation.
format Online
Article
Text
id pubmed-8725433
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87254332022-01-06 Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation Huang, Haipeng Itaya, Yukiko Samejima, Kouki Ichinose, Shunichiro Narita, Tatsuya Matsunaga, Shigetaka Saitoh, Masahiro Takai, Yasushi J Ovarian Res Research BACKGROUND: Progestin-primed ovarian stimulation (PPOS) has been used in infertility cases in recent years, and several reports have stated that it has oocyte collection results similar to those of gonadotropin-releasing hormone antagonist (GnRH-ant) protocol. For emergency fertility preservation, random-start ovarian stimulation is usually recommended. Therefore we compared the clinical outcomes of random-start PPOS with those of conventional random-start GnRH-ant protocols in fertility-preserving cases. METHODS: We retrospectively examined 86 cycles of oocyte collection, of which 56 were random-start GnRH-ant and 30 were random-start PPOS for fertility preservation at our hospital between January 2016 and April 2021. The primary outcome was the number of mature oocytes per cycle. The secondary outcome was the number of vitrified blastocysts per cycle for embryo freezing cases. RESULTS: No significant differences were noted in the number of days of stimulation, total dose of gonadotropin preparation, and the number of mature oocytes and vitrified blastocysts. The number of hospital visits for monitoring was significantly lower in the PPOS group. The start of menstruation before oocyte collection was significantly less in the PPOS group. CONCLUSIONS: Random-start PPOS and GnRH-ant were similar in oocyte collection results. PPOS can reduce the number of hospital visits, thus reducing patient stress. PPOS at the start of the luteal phase can prevent the start of menstruation during ovarian stimulation. BioMed Central 2022-01-04 /pmc/articles/PMC8725433/ /pubmed/34983605 http://dx.doi.org/10.1186/s13048-021-00935-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Huang, Haipeng
Itaya, Yukiko
Samejima, Kouki
Ichinose, Shunichiro
Narita, Tatsuya
Matsunaga, Shigetaka
Saitoh, Masahiro
Takai, Yasushi
Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation
title Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation
title_full Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation
title_fullStr Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation
title_full_unstemmed Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation
title_short Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation
title_sort usefulness of random-start progestin-primed ovarian stimulation for fertility preservation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725433/
https://www.ncbi.nlm.nih.gov/pubmed/34983605
http://dx.doi.org/10.1186/s13048-021-00935-5
work_keys_str_mv AT huanghaipeng usefulnessofrandomstartprogestinprimedovarianstimulationforfertilitypreservation
AT itayayukiko usefulnessofrandomstartprogestinprimedovarianstimulationforfertilitypreservation
AT samejimakouki usefulnessofrandomstartprogestinprimedovarianstimulationforfertilitypreservation
AT ichinoseshunichiro usefulnessofrandomstartprogestinprimedovarianstimulationforfertilitypreservation
AT naritatatsuya usefulnessofrandomstartprogestinprimedovarianstimulationforfertilitypreservation
AT matsunagashigetaka usefulnessofrandomstartprogestinprimedovarianstimulationforfertilitypreservation
AT saitohmasahiro usefulnessofrandomstartprogestinprimedovarianstimulationforfertilitypreservation
AT takaiyasushi usefulnessofrandomstartprogestinprimedovarianstimulationforfertilitypreservation